ID18741A - Zat nikotinat dalam terapi - Google Patents
Zat nikotinat dalam terapiInfo
- Publication number
- ID18741A ID18741A IDP973538A ID973538A ID18741A ID 18741 A ID18741 A ID 18741A ID P973538 A IDP973538 A ID P973538A ID 973538 A ID973538 A ID 973538A ID 18741 A ID18741 A ID 18741A
- Authority
- ID
- Indonesia
- Prior art keywords
- nicotinic
- therapy
- substance
- nicotinic substance
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/18—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Psychology (AREA)
- Child & Adolescent Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2880496P | 1996-10-30 | 1996-10-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ID18741A true ID18741A (id) | 1998-05-07 |
Family
ID=21845528
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IDP973538A ID18741A (id) | 1996-10-30 | 1997-10-28 | Zat nikotinat dalam terapi |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US6235734B1 (ja) |
| EP (1) | EP0937077B1 (ja) |
| JP (2) | JP3621707B2 (ja) |
| AP (1) | AP9701125A0 (ja) |
| AR (1) | AR008901A1 (ja) |
| AT (1) | ATE326468T1 (ja) |
| AU (1) | AU4394897A (ja) |
| DE (1) | DE69735891T2 (ja) |
| ES (1) | ES2264169T3 (ja) |
| GT (1) | GT199700115A (ja) |
| HR (1) | HRP970567A2 (ja) |
| ID (1) | ID18741A (ja) |
| MA (1) | MA26445A1 (ja) |
| PA (1) | PA8440201A1 (ja) |
| TN (1) | TNSN97168A1 (ja) |
| WO (1) | WO1998018798A1 (ja) |
| ZA (1) | ZA979706B (ja) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6717030B2 (en) * | 1998-07-06 | 2004-04-06 | The Regents Of The University Of California | Protein kinase C epsilon as modulator of anxiety, alcohol consumption and self-administration of drugs of abuse |
| IL137937A0 (en) * | 1999-08-27 | 2001-10-31 | Pfizer Prod Inc | A pharmaceutical composition for the prevention and treatment of nicotine addiction in a mammal |
| US20010036943A1 (en) * | 2000-04-07 | 2001-11-01 | Coe Jotham W. | Pharmaceutical composition for treatment of acute, chronic pain and/or neuropathic pain and migraines |
| US20020010192A1 (en) * | 2000-06-02 | 2002-01-24 | Coe Jotham Wadsworth | Pharmaceutical composition for the treatment of obesity or to facilitate or promote weight loss |
| US20020016334A1 (en) * | 2000-07-31 | 2002-02-07 | Coe Jotham Wadsworth | Pharmaceutical composition for the treatment of attention deficit hyperactivity disorder (ADHD) |
| ATE405574T1 (de) | 2001-11-30 | 2008-09-15 | Pfizer Prod Inc | Aryl-annellierte azapolyzyklische verbindungen |
| SE0104463D0 (sv) * | 2001-12-29 | 2001-12-29 | Carlbiotech Ltd As | Mellanprodukter för syntes af LHRH-antagonister, sätt att framställa dem och sätt för framställning av LHRH-antagonister |
| US20030162770A1 (en) | 2002-02-22 | 2003-08-28 | Davis Bonnie M. | Use of modulators of nicotinic receptors for treatment of cognitive dysfunction |
| US20040224963A1 (en) * | 2003-05-09 | 2004-11-11 | Pfizer Inc | Pharmaceutical composition for the prevention and treatment of nicotine addiction in a mammal |
| US20040224962A1 (en) * | 2003-05-09 | 2004-11-11 | Pfizer Inc | Pharmaceutical composition for the treatment of obesity or to facilitate or promote weight loss |
| US8030300B2 (en) | 2003-06-10 | 2011-10-04 | Georgetown University | Ligands for nicotinic acetylcholine receptors, and methods of making and using them |
| BRPI0412712A (pt) | 2003-07-21 | 2006-09-26 | Pfizer Prod Inc | compostos azapolicìclicos fundidos com heteroarila |
| US20050234024A1 (en) * | 2004-04-14 | 2005-10-20 | Clarke David E | Materials and methods for the treatment of ulcerative colitis |
| US7135933B2 (en) * | 2004-09-29 | 2006-11-14 | Intelliserv, Inc. | System for adjusting frequency of electrical output pulses derived from an oscillator |
| CA2591330A1 (en) * | 2004-12-07 | 2006-06-15 | Pfizer Products Inc. | 1, 2, 3, 3a, 8, 8a-hexahydro-2, 7a-diada-cyclopenta [a] inden-7-one derivatives which bind to neuronal nicotinic acetylcholine specific receptor sites and are useful in modulatingcholinergic function and in the treatment of addictive disorders |
| US20060211649A1 (en) * | 2005-03-21 | 2006-09-21 | Eric Marchewitz | Use of cytisine for enhancing physical performance |
| US20070134169A1 (en) * | 2005-12-11 | 2007-06-14 | Rabinoff Michael D | Methods for smoking cessation or alcohol cessation or other addiction cessation |
| EP1976519A2 (en) * | 2006-01-27 | 2008-10-08 | Yale University | Cytisine and acetylcholine analogs and methods of treating mood disorders |
| US20100048606A1 (en) * | 2006-03-29 | 2010-02-25 | Georgetown University Office of Technology Commercialization | 10-Substituted Cytisine Derivatives and Methods of Use Thereof |
| US7404725B2 (en) * | 2006-07-03 | 2008-07-29 | Hall David R | Wiper for tool string direct electrical connection |
| US8061443B2 (en) * | 2008-04-24 | 2011-11-22 | Schlumberger Technology Corporation | Downhole sample rate system |
| EP2516429B1 (en) | 2009-12-22 | 2020-06-24 | Avon Products, Inc. | Paxillin stimulating compositions and cosmetic uses thereof |
| US20110159125A1 (en) | 2009-12-29 | 2011-06-30 | Avon Products, Inc. | CGRP Compositions and Uses Thereof |
| FR2992315B1 (fr) * | 2012-06-25 | 2014-08-08 | Pf Medicament | Derives utiles dans le traitement de maladies du systeme nerveux central |
| US10154988B2 (en) | 2012-11-14 | 2018-12-18 | The Johns Hopkins University | Methods and compositions for treating schizophrenia |
| CN102952134B (zh) * | 2012-12-05 | 2015-01-07 | 苏州药明康德检测检验有限责任公司 | 含二氟甲基的金雀花碱衍生物及制备方法和抗癌作用研究 |
| RU2630958C2 (ru) * | 2015-12-29 | 2017-09-15 | федеральное государственное автономное образовательное учреждение высшего образования "Московский физико-технический институт (государственный университет)" (МФТИ) | Новые макроциклические соединения, содержащие природное 3,7-диазабицикло[3.3.1]нонановое ядро и способ их получения |
| GB201602145D0 (en) | 2016-02-05 | 2016-03-23 | Achieve Pharma Uk Ltd | Salt |
| ES2935204T3 (es) * | 2016-08-19 | 2023-03-02 | Univ Bristol | Derivados de citisina para el tratamiento de la adicción |
| CA3070055A1 (en) | 2017-07-24 | 2019-01-31 | Achieve Pharma Uk Limited | Cytisine salts |
| KR20220074895A (ko) * | 2019-09-12 | 2022-06-03 | 어치브 라이프 사이언시즈, 인크. | 필요로 하는 대상체의 중독 치료 및/또는 예방을 위한 시티신을 포함하는 조성물 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH658594A5 (de) * | 1982-02-22 | 1986-11-28 | Bruss Ni Sanitarno Gigieniches | Arzneipraeparat mit antinikotinwirkung und verfahren fuer seine herstellung. |
| US4835162A (en) * | 1987-02-12 | 1989-05-30 | Abood Leo G | Agonists and antagonists to nicotine as smoking deterents |
| US5242916A (en) * | 1992-07-07 | 1993-09-07 | R. J. Reynolds Tobacco Company | Method for treatment of neurodegenerative diseases |
| TW261531B (ja) * | 1993-10-28 | 1995-11-01 | Dynagen Inc | |
| EP0853621A1 (en) * | 1995-09-22 | 1998-07-22 | Novo Nordisk A/S | Novel substituted azacyclic or azabicyclic compounds |
-
1997
- 1997-10-15 US US09/297,109 patent/US6235734B1/en not_active Expired - Fee Related
- 1997-10-15 WO PCT/IB1997/001282 patent/WO1998018798A1/en active IP Right Grant
- 1997-10-15 JP JP52022898A patent/JP3621707B2/ja not_active Expired - Fee Related
- 1997-10-15 AU AU43948/97A patent/AU4394897A/en not_active Abandoned
- 1997-10-15 EP EP97942166A patent/EP0937077B1/en not_active Expired - Lifetime
- 1997-10-15 DE DE69735891T patent/DE69735891T2/de not_active Expired - Fee Related
- 1997-10-15 ES ES97942166T patent/ES2264169T3/es not_active Expired - Lifetime
- 1997-10-15 AT AT97942166T patent/ATE326468T1/de not_active IP Right Cessation
- 1997-10-23 AP APAP/P/1997/001125A patent/AP9701125A0/en unknown
- 1997-10-24 PA PA19978440201A patent/PA8440201A1/es unknown
- 1997-10-24 HR HR60/028,804A patent/HRP970567A2/hr not_active Application Discontinuation
- 1997-10-27 GT GT199700115A patent/GT199700115A/es unknown
- 1997-10-28 ID IDP973538A patent/ID18741A/id unknown
- 1997-10-28 AR ARP970104980A patent/AR008901A1/es unknown
- 1997-10-29 ZA ZA979706A patent/ZA979706B/xx unknown
- 1997-10-29 TN TNTNSN97168A patent/TNSN97168A1/fr unknown
- 1997-10-29 MA MA24849A patent/MA26445A1/fr unknown
-
2001
- 2001-02-14 US US09/783,443 patent/US6630467B2/en not_active Expired - Fee Related
-
2004
- 2004-09-21 JP JP2004273910A patent/JP2005060403A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| MA26445A1 (fr) | 2004-12-20 |
| AP9701125A0 (en) | 1997-10-31 |
| AU4394897A (en) | 1998-05-22 |
| AR008901A1 (es) | 2000-02-23 |
| DE69735891D1 (de) | 2006-06-22 |
| US6630467B2 (en) | 2003-10-07 |
| ES2264169T3 (es) | 2006-12-16 |
| PA8440201A1 (es) | 2000-05-24 |
| DE69735891T2 (de) | 2006-12-14 |
| HRP970567A2 (en) | 1998-10-31 |
| JP2000505809A (ja) | 2000-05-16 |
| EP0937077B1 (en) | 2006-05-17 |
| ZA979706B (en) | 1999-04-29 |
| US6235734B1 (en) | 2001-05-22 |
| JP2005060403A (ja) | 2005-03-10 |
| ATE326468T1 (de) | 2006-06-15 |
| JP3621707B2 (ja) | 2005-02-16 |
| GT199700115A (es) | 1999-04-20 |
| EP0937077A1 (en) | 1999-08-25 |
| US20030065173A1 (en) | 2003-04-03 |
| WO1998018798A1 (en) | 1998-05-07 |
| TNSN97168A1 (fr) | 2005-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ID18741A (id) | Zat nikotinat dalam terapi | |
| NO983560D0 (no) | Triazolderivater nyttige i terapi | |
| ID17948A (id) | Piridine bersumbu heterosiklik | |
| BR9612263A (pt) | Compostos quinolina e qinazolina úteis em terapia | |
| FI970762A (fi) | Terapiassa käyttökelpoiset spiroatsabisykliset yhdisteet | |
| PT869126E (pt) | Derivados de ditiolano, sua preparacao e seus efeitos terapeuticos | |
| TR199501305A2 (tr) | Heterosiklik bilesikler ve bunlarin hazirlanmasi ve kullanimi | |
| EE9800042A (et) | Inhalaatorites kasutatav seade | |
| NO982435D0 (no) | Blodoppvarmingsapparat | |
| EE03439B1 (et) | Teraapias kasutatavad bitsüklilised isotiokarbamiidi derivaadid | |
| DE59710593D1 (de) | Therapiegerät | |
| NO964541D0 (no) | Porphacyanin og CNC-utvidete porphyriner | |
| DE59711085D1 (de) | Therapiegerät | |
| DK0826679T3 (da) | Naphthylforbindelser og -præparater | |
| EE9800333A (et) | Uued furaandiarüülmetülideeni derivaadid, nende valmistamise meetod ja kasutamine teraapias | |
| ID16978A (id) | Zat pelindung kulit | |
| DE69634991D1 (de) | Elektrotherapiegerät | |
| SE9602645D0 (sv) | Azabicyclic derivatives useful in therapy | |
| BR7601811U (pt) | Disposição introduzida em fralda | |
| BR7400430U (pt) | Disposição introduzida em guarda-roupa | |
| BR9700076A (pt) | Aperfeiçoamento introduzido em prótese cardáica | |
| BR7601750U (pt) | Disposição introduzida em semeadeira | |
| BR7400422U (pt) | Disposição introduzida em guarda-sol | |
| BR7602255U (pt) | Disposição introduzida em cobertura | |
| EE00130U1 (et) | Muda-parafiinimarlis |